Page last updated: 2024-11-04

sanguinarine and Osteoporosis, Postmenopausal

sanguinarine has been researched along with Osteoporosis, Postmenopausal in 1 studies

benzophenanthridine alkaloid : A specific group of isoquinoline alkaloids that occur only in higher plants and are constituents mainly of the Papaveraceae family.

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research Excerpts

ExcerptRelevanceReference
"Sanguinarine treatment (0."1.48Anti-osteoporosis activity of Sanguinarine in preosteoblast MC3T3-E1 cells and an ovariectomized rat model. ( Wang, G; Xie, J; Yang, H; Zhang, F; Zhang, G, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, F1
Xie, J1
Wang, G1
Zhang, G1
Yang, H1

Other Studies

1 other study available for sanguinarine and Osteoporosis, Postmenopausal

ArticleYear
Anti-osteoporosis activity of Sanguinarine in preosteoblast MC3T3-E1 cells and an ovariectomized rat model.
    Journal of cellular physiology, 2018, Volume: 233, Issue:6

    Topics: 3T3 Cells; AMP-Activated Protein Kinases; Animals; Benzophenanthridines; Bone Density; Bone Density

2018